Sino-Singapore Health and Tianjin University jointly develops female-specific nanomedicine for Alzheimer's disease. The disease progression rate and death rate of female patients are 2 to 3 times that of men.
Research suggests that the significant drop in estrogen levels in women after menopause may be a contributing factor to a greater risk of developing the disease. Estrogen plays an important role in protecting the central nervous system in women. It works with specific estrogen receptors in the brain to promote neuronal growth and differentiation and maintain redox homeostasis.